NCT06782061View on ClinicalTrials.gov

Activation of NOD2 Receptors in Preterm Infants by Lactobacillus Reuteri DSM17938

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 26, 2024

Primary Completion Date

January 19, 2025

Study Completion Date

January 19, 2025

Conditions
Preterm Infants
Interventions
OTHER

DSM17938+Routine clinical treatment

Lactobacillus reuteri DSM17938，5 drops per day by mouth (containing at least 100 million CFU of Lactobacillus reuteri DSM17938)，Routine clinical treatment

Trial Locations (1)

510515

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER

NCT06782061 - Activation of NOD2 Receptors in Preterm Infants by Lactobacillus Reuteri DSM17938 | Biotech Hunter | Biotech Hunter